Pre-operative apparent diffusion coefficient values and tumour region volumes as prognostic biomarkers in glioblastoma: correlation and progression-free survival analyses

被引:14
作者
Durand-Munoz, Coral [1 ]
Flores-Alvarez, Eduardo [2 ]
Moreno-Jimenez, Sergio [3 ]
Roldan-Valadez, Ernesto [4 ,5 ]
机构
[1] Med Clin & Fdn, Dept Internal Med, Mexico City, DF, Mexico
[2] Gen Hosp Mexico, Dept Neurosurg, Secretariat Hlth, Mexico City, DF, Mexico
[3] Natl Inst Neurol & Neurosurg, Radioneurosurg Unit, Mexico City, DF, Mexico
[4] Gen Hosp Mexico, Directorate Res, Secretariat Hlth, Mexico City, DF, Mexico
[5] Sechenov Univ, IM Sechenov Moscow State Med Univ 1, Dept Radiol, Trubetskaya Str 8,B 2, Moscow 119992, Russia
关键词
Brain neoplasms; Diffusion magnetic resonance imaging; Glioblastoma; Neuroimaging; Regression analysis; Progression-free survival; MRI; MULTIFORME; TEMOZOLOMIDE; THERAPY; GLIOMAS; PREDICT; EDEMA;
D O I
10.1186/s13244-019-0724-8
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
ObjectivesGlioblastoma (GB) contains diverse histologic regions. Apparent diffusion coefficient (ADC) values are surrogates for the degree of number of cells within the tumour regions. Because an assessment of ADC values and volumes within tumour sub-compartments of GB is missing in the literature, we aimed to evaluate these associations.MethodsA retrospective cohort of 48 patients with GB underwent segmentation to calculate tumour region volumes (in cubic centimetre) and ADC values in tumour regions: normal tissue, enhancing tumour, proximal oedema, distal oedema, and necrosis. Correlation, Kaplan-Meier, and Cox hazard regression analyses were performed.ResultsWe found a statistically significant difference among ADC values for tumour regions: F (4, 220)=166.71 and p.001 and tumour region volumes (necrosis, enhancing tumour, peritumoural oedema): F (2, 141)=136.3 and p.001. Post hoc comparisons indicated that the only significantly different mean score was the peritumoural volume in oedema region (p<.001). We observed a positive significant correlation between ADC of distal oedema and peritumoural volume, r=.418, df=34, and p=.011. Cox proportional hazards regression analysis considering only tumour region volumes provided an almost significant model: -2 log-likelihood=146.066, (2) (4)=9.303, and p=.054 with a trend towards significance of the hazard function: p=.067 and HR=1.077 for the non-enhancing tumour volume.ConclusionsADC values together with volumes of oedema region might have a role as predictors of progression-free survival (PFS) in patients with GB; we recommend a routine MRI assessment with the calculation of these biomarkers in GB.
引用
收藏
页数:10
相关论文
共 43 条
  • [1] [Anonymous], JMRI
  • [2] Grading of Gliomas by Using Monoexponential, Biexponential, and Stretched Exponential Diffusion-weighted MR Imaging and Diffusion Kurtosis MR Imaging
    Bai, Yan
    Lin, Yusong
    Tian, Jie
    Shi, Dapeng
    Cheng, Jingliang
    Haacke, E. Mark
    Hong, Xiaohua
    Ma, Bo
    Zhou, Jinyuan
    Wang, Meiyun
    [J]. RADIOLOGY, 2016, 278 (02) : 496 - 504
  • [3] Cohen JW., 1988, STAT POWER ANAL BEHA, DOI 10.4324/9780203771587
  • [4] Diagnostic performance of regional DTI-derived tensor metrics in glioblastoma multiforme: simultaneous evaluation of p, q, L, Cl, Cp, Cs, RA, RD, AD, mean diffusivity and fractional anisotropy
    Cortez-Conradis, David
    Favila, Rafael
    Isaac-Olive, Keila
    Martinez-Lopez, Manuel
    Rios, Camilo
    Roldan-Valadez, Ernesto
    [J]. EUROPEAN RADIOLOGY, 2013, 23 (04) : 1112 - 1121
  • [5] Medical progress: Brain tumors
    DeAngelis, LM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (02) : 114 - 123
  • [6] Diffusion MRI Phenotypes Predict Overall Survival Benefit from Anti-VEGF Monotherapy in Recurrent Glioblastoma: Converging Evidence from Phase II Trials
    Ellingson, Benjamin M.
    Gerstner, Elizabeth R.
    Smits, Marion
    Huang, Raymond Y.
    Colen, Rivka
    Abrey, Lauren E.
    Aftab, Dana T.
    Schwab, Gisela M.
    Hessel, Colin
    Harris, Robert J.
    Chakhoyan, Ararat
    Gahrmann, Renske
    Pope, Whitney B.
    Leu, Kevin
    Raymond, Catalina
    Woodworth, Davis C.
    de Groot, John
    Wen, Patrick Y.
    Batchelor, Tracy T.
    van den Bent, Martin J.
    Cloughesy, Timothy F.
    [J]. CLINICAL CANCER RESEARCH, 2017, 23 (19) : 5745 - 5756
  • [7] Graded functional diffusion map-defined characteristics of apparent diffusion coefficients predict overall survival in recurrent glioblastoma treated with bevacizumab
    Ellingson, Benjamin M.
    Cloughesy, Timothy F.
    Lai, Albert
    Mischel, Paul S.
    Nghiemphu, Phioanh L.
    Lalezari, Shadi
    Schmainda, Kathleen M.
    Pope, Whitney B.
    [J]. NEURO-ONCOLOGY, 2011, 13 (10) : 1151 - 1161
  • [8] Evaluation of absolute and normalized apparent diffusion coefficient (ADC) values within the post-operative T2/FLAIR volume as adverse prognostic indicators in glioblastoma
    Elson, Andrew
    Bovi, Joseph
    Siker, Malika
    Schultz, Chris
    Paulson, Eric
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2015, 122 (03) : 549 - 558
  • [9] MR Imaging Predictors of Molecular Profile and Survival: Multi-institutional Study of the TCGA Glioblastoma Data Set
    Gutman, David A.
    Cooper, Lee A. D.
    Hwang, Scott N.
    Holder, Chad A.
    Gao, JingJing
    Aurora, Tarun D.
    Dunn, William D., Jr.
    Scarpace, Lisa
    Mikkelsen, Tom
    Jain, Rajan
    Wintermark, Max
    Jilwan, Manal
    Raghavan, Prashant
    Huang, Erich
    Clifford, Robert J.
    Mongkolwat, Pattanasak
    Kleper, Vladimir
    Freymann, John
    Kirby, Justin
    Zinn, Pascal O.
    Moreno, Carlos S.
    Jaffe, Carl
    Colen, Rivka
    Rubin, Daniel L.
    Saltz, Joel
    Flanders, Adam
    Brat, Daniel J.
    [J]. RADIOLOGY, 2013, 267 (02) : 560 - 569
  • [10] Effect of 10 different polymorphisms on preoperative volumetric characteristics of glioblastoma multiforme
    Henker, Christian
    Kriesen, Thomas
    Fuerst, Katharina
    Goody, Deborah
    Glass, Aenne
    Puetzer, Brigitte M.
    Piek, Juergen
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2016, 126 (03) : 585 - 592